Novo Nordisk A/S (NVO) Stock Price & Financial Analysis
Novo Nordisk A/S Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Novo Nordisk A/S
What is the current stock price for NVO?
As of the latest trading session, NVO stock trades at $45.07. The 52-week range is $35.12–$81.44, with a day range of $44.43–$45.25.
What is the P/E ratio for NVO?
Novo Nordisk A/S's trailing P/E ratio is 12.4, meaning investors pay $12.4 for every $1 of annual earnings. The forward P/E is 12.4, reflecting analyst expectations for future earnings. Novo Nordisk A/S operates in the Healthcare sector.
Does NVO pay dividends?
Yes, Novo Nordisk A/S pays a 6.53% annual dividend yield ($2.94 per share). The payout ratio is 82.2%. The last ex-dividend date was 2027-04-08.
What do analysts recommend for NVO?
Based on 2 analysts, the consensus for NVO is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of NVO?
Novo Nordisk A/S's market capitalization is $200.46B, classifying it as a mega-cap company. Novo Nordisk A/S operates in the Healthcare sector within the Drug Manufacturers - General industry.